Yüklüyor......
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Antibody-dependent cell-mediated cytotoxicity (ADCC), which is largely mediated by natural killer (NK) cells, is thought to play an important role in the efficacy of rituximab, an anti-CD20 monoclonal antibody (mAb) used to treat patients with B-cell lymphomas. CD137 is a costimulatory molecule expr...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3062409/ https://ncbi.nlm.nih.gov/pubmed/21193697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-08-301945 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|